REGISTER TODAY!
Register your email address with us so we can be in touch with the information you need - when you need it most.
C-MAP LAUNCHED
MMRF & Onyx launch Carfilzomib Myeloma Access Program (C-MAP) for patients with multiple myeloma. Click here to learn more.
Dealing with relapsed/refractory disease has its own unique challenges. Here you will learn about the latest treatment options and find the help you need to navigate through this next phase in your multiple myeloma disease.